Julphar is an Emirati pharmaceutical manufacturer in the Middle East. Headquartered in Ras Al Khaimah, United Arab Emirates, the company employs more than 5,000 people and distributes its pharmaceutical products internationally. The company has three divisions — General Medicines, Julphar Diabetes Solutions and Julphar Life — with products having applications in Gastrology, Pain Management, Respiratory, Wounds and Scars, Gastrointestinal Tract, Gynecology, Men’s Health, Anemia, Anti-infectives, Neurology, Dermatology, Cardiology, Dietary Supplements and Vitamins. In 2018, the company was ranked as the number one pharmaceutical manufacturer in the UAE. Julphar was established in 1980. The company obtained Ministry of Health approval for its first 30 products four years later and began manufacturing liquids and semi-solids in 1988. In 1990, distribution agents were established in key markets across the globe and work began on the construction of new manufacturing facilities in Ras Al Khaimah. Julphar II, III and IV were launched in 1998, a biotechnology plant, Julphar VII, was launched in 2003 and Julphar VIII, IX and X were launched in 2007. Julphar’s transportation and shipping division, MenaCool, was launched in 2008 to transport the company’s medicines across the MENA region. In 2011, Julphar crossed AED 1 billion in sales, an 11.3% growth from 2010. Julphar began producing biosimilars in 2012 and launched a new division, Julphar Diabetes Solutions, becoming the only company in the Middle East and North Africa to locally produce Recombinant DNA (r-DNA), the raw material used to make insulin. Julphar inaugurated its first facility on the African continent with the opening of Julphar Ethiopia in 2013. The launch of Julphar Bangladesh took place two years later in 2015, which coincided with the launch of Julphar Life, the company’s consumer division. In 2017, Julphar acquired IV fluid company, Gulf Inject and officially opened a facility in Saudi Arabia in collaboration with its local partner, Cigalah Group. In 2018, Julphar signed an agreement with the Ministry of Health (United Arab Emirates) to ensure the availability of critical medical supplies during crisis situations. Julphar won the Association of Strategic Alliance Professionals award in 2018 along with its partner, Merck & Co., becoming the first pharmaceutical company from the Middle East and Africa to win such an award. The company also won the Frost & Sullivan 2018 Best Emerging GCC Pharmaceutical Manufacturing Company of the Year award.


Medical Representative (Dubai)Dubai, United Arab Emirates22 Mar 2024
Medical Representative (Abu Dhabi)Dubai, United Arab Emirates31 Mar 2024
Manager-Project ITRas Al khaima, United Arab Emirates22 Mar 2024
Team Leader – ProcurementRas Al khaima, United Arab Emirates23 Mar 2024
Manager – Internal AuditRas Al khaima, United Arab Emirates26 Mar 2024
HRBP-Talent Management & ODRas Al khaima, United Arab Emirates22 Mar 2024
Specialist – PlanningRas Al khaima, United Arab Emirates22 Mar 2024
Product Lifecycle ManagerRas Al khaima, United Arab Emirates24 Mar 2024
Manager – Demand PlanningRas Al khaima, United Arab Emirates18 Mar 2024
Sr. Manager – PMORas Al khaima, United Arab Emirates11 Apr 2024

apply now

kingscollegehospitaldubai : latest vacancies are

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2024 Pravasiclick - WordPress Theme by WPEnjoy